⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002000002

Kalayoglu Murat

Reports to the SEC for 1 company · WASHINGTON, DC

Transactions

19

Companies

1

Filings

7

CIK

0002000002

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-02	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+758K sh	—	—	5,313,261
2026-04-02	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockM Exercise/Conversion	10% Owner	MExercise/Conversion	−22.7K sh	—	—	33,662.224
2026-01-02	RNACCartesian Therapeutics, Inc.A Award	10% Owner	AAward	+2,600 sh	—	—	511,577
2026-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+7,800 sh	—	—	7,800
2025-01-02	RNACCartesian Therapeutics, Inc.A Award	10% Owner	AAward	+2,600 sh	—	—	508,977
2025-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+7,800 sh	—	—	7,800
2024-10-11	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+1.52M sh	—	—	4,555,260
2024-10-11	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockM Exercise/Conversion	10% Owner	MExercise/Conversion	−45.6K sh	—	—	56,402.254
2024-04-08	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+492K sh	—	—	506,377
2024-04-08	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+2.93M sh	—	—	3,036,887
2024-04-08	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockM Exercise/Conversion	10% Owner	MExercise/Conversion	−14.8K sh	—	—	0
2024-04-08	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockM Exercise/Conversion	10% Owner	MExercise/Conversion	−87.8K sh	—	—	101,953.444
2024-01-02	RNACCartesian Therapeutics, Inc.A Award	10% Owner	AAward	+178K sh	—	—	435,739
2024-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+228K sh	—	—	228,000
2023-11-13	RNACCartesian Therapeutics, Inc.A Award	10% Owner	AAward	+258K sh	—	—	257,739
2023-11-13	RNACCartesian Therapeutics, Inc.J Other	10% Owner	JOther	+3.3M sh	—	—	3,303,699
2023-11-13	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockA Award	10% Owner	AAward	+14.8K sh	—	—	14,755.609
2023-11-13	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockJ Other	10% Owner	JOther	+189K sh	—	—	189,136.767
2023-11-13	RNACCartesian Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockP Purchase	10% Owner	PPurchase	+619.627 sh	$249999.98	+$155M	619.627

Recent filings

7

Accepted (ET)
Apr 64
Kalayoglu Murat0002064832-26-000148
SEC(opens sec.gov)
Jan 64
Kalayoglu Murat0001453687-26-000028
SEC(opens sec.gov)
Jan 64
Kalayoglu Murat0001453687-25-000022
SEC(opens sec.gov)
Oct 154
Kalayoglu Murat0001453687-24-000117
SEC(opens sec.gov)
Apr 104
Kalayoglu Murat0001453687-24-000065
SEC(opens sec.gov)
Jan 44
Kalayoglu Murat0001453687-24-000017
SEC(opens sec.gov)
Nov 154
Kalayoglu Murat0001062993-23-020921
SEC(opens sec.gov)

Companies

1

Cartesian Therapeutics, Inc.10% OwnerRNAC

Address

C/O SOAR BIO, LLC 7144 13TH PL NW

WASHINGTON, DC, 20012